KPNA2 and endothelial dysfunction: FBXW7 can also degrade KPNA2 (karyopherin subunit alpha 2) through ubiquitination, thereby alleviating endothelial dysfunction and inflammatory responses by inhibiting p65 and interferon regulatory factor 3 (43).